RD&C developed a novel systemic analysis concept for impurity profiling in pharmaceutical drug process development and impurity related deviation management at development stage or in routine drug manufacturing.
The unique data base for impurities, degradation products and E&L is compiling relevant data and information comprising structural information, measured and calculated physico-chemical data, information on toxicology, safety and regulatory issues.
The method could be used for prediction of stability, polymorph changes, shelf-life, degradations in solid environment as well as development tool for solid formulations. The service is offered to customers, but is also open for out-licensing.
This accredited chartered engineer status warrants fitness for combining a broad technical background with an objective view, directed towards protecting the clients’ interests and ensuring superior performance at the lowest commensurate cost. Chartered engineer status ensures quality, employability and professional recognition.
Highly cost efficient Environmental Risk Assessments (ERAs) at a minimum of experimental effort through profound chemical understanding, the application of in silico software tools and a systemic analysis approach.
The expert status is announced for 5 years comprises the fields pharmaceutical chemistry, pharmaceutical products and cosmetics.
The RD&C team is responsible for section 2 "Drug Discovery Technologies". The book will be published 2016/17.